von Arnim_2019_Z.Gerontol.Geriatr_52_309

Reference

Title : Diagnosis and treatment of cognitive impairment - von Arnim_2019_Z.Gerontol.Geriatr_52_309
Author(s) : von Arnim CAF , Bartsch T , Jacobs AH , Holbrook J , Bergmann P , Zieschang T , Polidori MC , Dodel R
Ref : Z Gerontol Geriatr , 52 :309 , 2019
Abstract :

As a result of the aging population dementia is a growing challenge, especially in healthcare. Nevertheless, cognitive disorders are often not systematically evaluated, especially during hospital stays for other reasons; however, cognitive impairment is associated with a number of geriatric syndromes, including falls, delirium, dysphagia and lack of adherence to treatment plans. This article considers the current state of diagnosis and treatment of dementia. Non-pharmacological therapeutic approaches as well as current and future pharmacological treatment options are discussed. The drugs of choice for the symptomatic treatment of cognitive deficits in Alzheimer's disease and Parkinson-associated dementia are cholinesterase inhibitors and memantine; there is no specific pharmacological treatment for other types of dementia. Prevention and treatment of cardiovascular risk factors can potentially retard the progression of possibly all forms of dementia.

PubMedSearch : von Arnim_2019_Z.Gerontol.Geriatr_52_309
PubMedID: 31161337

Related information

Citations formats

von Arnim CAF, Bartsch T, Jacobs AH, Holbrook J, Bergmann P, Zieschang T, Polidori MC, Dodel R (2019)
Diagnosis and treatment of cognitive impairment
Z Gerontol Geriatr 52 :309

von Arnim CAF, Bartsch T, Jacobs AH, Holbrook J, Bergmann P, Zieschang T, Polidori MC, Dodel R (2019)
Z Gerontol Geriatr 52 :309